Medicus Pharma Ltd (MDCX)

Medicus Pharma Ltd has seen no insider trading activity within the last three months. The most recent transactions occurred on May 20, 2025, involving a sale and a proposed sale by Velocity Fund Partners, LP. Prior to this, various senior officers and directors engaged in buying activity throughout 2024.
Ticker: MDCX Exchange: NAS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.4
VELOCITY FUND PARTNERS, LP Major Shareholders
Transaction date
Proposed sale
Price
418.86
Quantity 81,403
Value US$936,529
Quinlan, James P Senior Officer of Issuer Officer
Transaction date
Purchase
Price
261.95
Quantity 17,822 -0.5%
Value US$1,367,394
Brennan, Jr., Edward Joseph Senior Officer of Issuer Officer
Transaction date
Purchase
Price
4.13
Quantity 24,242 +38.8%
Value US$99,998
Quinlan, James P Senior Officer of Issuer Officer
Transaction date
Purchase
Price
1.23
Quantity 1,245 +0.6%
Value US$1,527
Monaco, Erica Lee Senior Officer of Issuer Officer
Transaction date
Purchase
Price
1.23
Quantity 1,868 +2.5%
Value US$2,291
Lavelle, Francis W. Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
2.00
Quantity 1,245 +2.5%
Value US$2,490
Bonner, Carolyn Senior Officer of Issuer Officer
Transaction date
Purchase
Price
1.23
Quantity 311 +0.8%
Value US$381
Bokhari, Raza Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
1.23
Quantity 3,736 +0.2%
Value US$4,583
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2025-05-21 2025-05-20 S Sale Large shareholder
60,166 +1.9%
284.44
US$2,494,295
60,166 +1.9% 284.44 US$2,494,295
2025-05-20 2025-05-20 PrS Proposed sale

Major Shareholders

81,403
418.86
US$936,529
81,403 418.86 US$936,529
2024-11-20 2024-11-15 B Purchase

Senior Officer of Issuer

Officer
17,822 -0.5%
261.95
US$1,367,394
17,822 -0.5% 261.95 US$1,367,394
2024-11-20 2024-11-15 B Purchase

Senior Officer of Issuer

Officer
24,242 +38.8%
4.13
US$99,998
24,242 +38.8% 4.13 US$99,998
2024-07-26 2024-06-28 B Purchase

Senior Officer of Issuer

Officer
1,245 +0.6%
1.23
US$1,527
1,245 +0.6% 1.23 US$1,527
2024-07-26 2024-06-28 B Purchase

Senior Officer of Issuer

Officer
1,868 +2.5%
1.23
US$2,291
1,868 +2.5% 1.23 US$2,291
2024-07-26 2024-06-28 B Purchase

Director of Issuer

Non-Executive Director
1,245 +2.5%
2.00
US$2,490
1,245 +2.5% 2.00 US$2,490
2024-07-26 2024-06-28 B Purchase

Senior Officer of Issuer

Officer
311 +0.8%
1.23
US$381
311 +0.8% 1.23 US$381
2024-07-26 2024-06-28 B Purchase

Director of Issuer, Senior Officer of Issuer

Executive Director
3,736 +0.2%
1.23
US$4,583
3,736 +0.2% 1.23 US$4,583